Association Between Ancestry-specific 6q25 Variants And Breast Cancer Subtypes In Peruvian Women

Authors

Valentina A. Zavala, University of California, Davis
Sandro Casavilca-Zambrano, Instituto Nacional de Enfermedades Neoplasicas
Jeannie Navarro-Vásquez, Instituto Nacional de Enfermedades Neoplasicas
Carlos A. Castañeda, Instituto Nacional de Enfermedades Neoplasicas
Guillermo Valencia, Instituto Nacional de Enfermedades Neoplasicas
Zaida Morante, Instituto Nacional de Enfermedades Neoplasicas
Monica Calderón, Instituto Nacional de Enfermedades Neoplasicas
Julio E. Abugattas, Instituto Nacional de Enfermedades Neoplasicas
Henry Gómez, Instituto Nacional de Enfermedades Neoplasicas
Hugo A. Fuentes, Instituto Nacional de Enfermedades Neoplasicas
Ruddy Liendo-Picoaga, Instituto Nacional de Enfermedades Neoplasicas
Jose M. Cotrina, Instituto Nacional de Enfermedades Neoplasicas
Claudia Monge, Instituto Nacional de Enfermedades Neoplasicas
Silvia P. Neciosup, Instituto Nacional de Enfermedades Neoplasicas
Scott Huntsman, University of California, San Francisco
Donglei Hu, University of California, San Francisco
Sixto E. Sánchez, Universidad Peruana de Ciencias Aplicadas
Michelle A. Williams, Harvard T.H. Chan School of Public Health
Angel Núñez-Marrero, Ponce Health Sciences University
Lenin Godoy, Ponce Health Sciences University
Aaron Hechmer, UCSF Helen Diller Family Comprehensive Cancer Center
Adam B. Olshen, UCSF Helen Diller Family Comprehensive Cancer Center
Julie Dutil, Ponce Health Sciences University
Elad Ziv, University of California, San Francisco
Jovanny Zabaleta, LSUHSC School of Medicine
Bizu Gelaye, Harvard T.H. Chan School of Public Health
Jule Vásquez, Instituto Nacional de Enfermedades Neoplasicas
Marco Gálvez-Nino, Instituto Nacional de Enfermedades Neoplasicas

Document Type

Article

Publication Date

8-1-2022

Publication Title

Cancer Epidemiology Biomarkers and Prevention

Abstract

Background: Breast cancer incidence in the United States is lower in Hispanic/Latina (H/L) compared with African American/ Black or Non-Hispanic White women. An Indigenous American breast cancer-protective germline variant (rs140068132) has been reported near the estrogen receptor 1 gene. This study tests the association of rs140068132 and other polymorphisms in the 6q25 region with subtype-specific breast cancer risk in H/Ls of high Indigenous American ancestry. Methods: Genotypes were obtained for 5,094 Peruvian women with (1,755) and without (3,337) breast cancer. Associations between genotype and overall and subtype-specific risk for the protective variant were tested using logistic regression models and conditional analyses, including other risk-associated polymorphisms in the region. Results: We replicated the reported association between rs140068132 and breast cancer risk overall [odds ratio (OR), 0.53; 95% confidence interval (CI), 0.47-0.59], as well as the lower odds of developing hormone receptor negative (HR-) versus HR+ disease (OR, 0.77; 95% CI, 0.61-0.97). Models, including HER2, showed further heterogeneity with reduced odds for HR+HER2+ (OR, 0.68; 95% CI, 0.51-0.92), HR-HER2+ (OR, 0.63; 95% CI, 0.44-0.90) and HR-HER2- (OR, 0.77; 95% CI, 0.56-1.05) compared with HR+HER2-. Inclusion of other risk-associated variants did not change these observations. Conclusions: The rs140068132 polymorphism is associated with decreased risk of breast cancer in Peruvians and is more protective against HR- and HER2+ diseases independently of other breast cancer-associated variants in the 6q25 region. Impact: These results could inform functional analyses to understand the mechanism by which rs140068132-G reduces risk of breast cancer development in a subtype-specific manner. They also illustrate the importance of including diverse individuals in genetic studies.

First Page

1602

Last Page

1609

PubMed ID

35654312

Volume

31

Issue

8 August

Share

COinS